Back

Quality of life measured in first-line therapy during the Cryo-FIRST study: a comparison between cryoballoon catheter ablation versus antiarrhythmic drug therapy

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Arrhythmias, General ePosters Catheter Ablation of Arrhythmias ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Gian Battista Chierchia

Heart Rhythm Management Centre, Brussels (Belgium)

100 More presentations in this session

Presentation thumbnail
Beneficial electrophysiologic effects of sacubitril in different arrhythmia syndromes
Professor G. Frommeyer (Munster, DE)
Abstract Slides
Presentation thumbnail
Inflammation of conduction tissue in patients with arrhythmic phenotype of myocarditis
Doctor A. Frustaci (Rome, IT)
Abstract Slides
Presentation thumbnail
The pleiotropic effect of a deleterious DES mutation in familial atrial fibrillation and the role of PDE4DIP as a genetic modifier for heart block
Doctor M. Abou Ziki (New Haven, US)
Abstract Slides
Presentation thumbnail
Gen-editing to model Short QT syndrome type 5 using human-induced pluripotent stem cell-derived cardiomyocytes
Mr L. Maywald (Mannheim, DE)
Abstract Slides
Presentation thumbnail
Inducibility of atrial fibrillation is associated with disturbed activation pattern in bachmanns bundle
Ms L. van Staveren (Rotterdam, NL)
Abstract Slides

Access the full session

Session thumbnail
Arrhythmias, General ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
A prospective, multicenter, nationwide, observational study of flecainide controlled release on the quality of life of patients with atrial fibrillation in Greece, the REFLEC-CR study
3 September 2019
thumbnail
Congress Presentation
One shot "fire & ice"
7 April 2024
thumbnail
Congress Presentation
Quality-of-life improvement of the 100 patients treated over the Valvosoft prospective, multi-centre, single-arm first-in-human and pivotal studies: 12 month follow-up.
31 August 2025
thumbnail
Congress Presentation
Cryoablation as first-line treatment for persistent atrial fibrillation.
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources